(2S)-2-(6-chloro-9H-carbazol-2-yl)propanoic acid

0LA is found in 3 entries

0LA as free ligands, exist in 3 entries. Examples include 4DO3, 4MJR, 5FXT

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name (2S)-2-(6-chloro-9H-carbazol-2-yl)propanoic acid
Identifiers (2S)-2-(6-chloranyl-9H-carbazol-2-yl)propanoic acid
Synonyms (S)-carprofen
Formula C15 H12 Cl N O2
Molecular Weight 273.71 g/mol
Type non-polymer
Isomeric SMILES C[C@H](C(O)=O)c1ccc2c(c1)[nH]c1ccc(Cl)cc21
InChI InChI=1S/C15H12ClNO2/c1-8(15(18)19)9-2-4-11-12-7-10(16)3-5-13(12)17-14(11)6-9/h2-8,17H,1H3,(H,18,19)/t8-/m0/s1

Chemical Details

Formal Charge 0
Atom Count 31
Chiral Atom Count 1
Chiral Atoms C10
Bond Count 33
Aromatic Bond Count 15

Drug Info: DrugBank

DrugBank ID DB00821   (Different stereochemistry)
Name Carprofen
  • approved
  • vet_approved
  • withdrawn
Description Carprofen is a non-steroidal anti-inflammatory drug (NSAID) that is used by veterinarians as a supportive treatment for the relief of arthritic symptoms in geriatric dogs. Carprofen was previously used in human medicine for over 10 years (1985-1995). It was generally well tolerated, with the majority of adverse effects being mild, such as gastro-intestinal pain and nausea, similar to those recorded with aspirin and other non-steroidal anti-inflammatory drugs. It is no longer marketed for human usage, after being withdrawn on commercial grounds. [Wikipedia]
  • (+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid
  • (+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid
  • 2-(6-Chloro-9H-carbazol-2-yl)-propionic acid
  • 6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid
  • Carprofen
Brand Names
  • Rimadyt
  • lmadyl
  • lmafen
Affected Organism Humans and other mammals
Indication For use as a pain reliever in the treatment of joint pain and post-surgical pain.
Pharmacology Carprofen is a non-steroidal anti-inflammatory drug (NSAID) of the propionic acid class that includes ibuprofen, naproxen, and ketoprofen. It is no longer used in the clinical setting, but is approved for use in dogs. Carprofen is non-narcotic and has characteristic analgesic and antipyretic activity approximately equipotent to indomethacin in animal models.
Mechanism of action The mechanism of action of carprofen, like that of other NSAIDs, is believed to be associated with the inhibition of cyclooxygenase activity. Two unique cyclooxygenases have been described in mammals. The constitutive cyclooxygenase, COX-1, synthesizes prostaglandins necessary for normal gastrointestinal and renal function. The inducible cyclooxygenase, COX-2, generates prostaglandins involved in inflammation. Inhibition of COX-1 is thought to be associated with gastrointestinal and renal toxicity while inhibition of COX-2 provides anti-inflammatory activity. In an in vitro study using canine cell cultures, carprofen demonstrated selective inhibition of COX-2 versus COX-1.
  • Analgesics
  • Analgesics, Non-Narcotic
  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents
CAS number 53716-49-7
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682